Officials at DexCom discuss the company's Q4 2013 earnings. The company reported losses of $2.6 million, or 4¢ per share, on sales of $51.3 million for the 3 months ended December 31, for losses narrowed by 70% on sales growth of 62%.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1haMUJ8
Cap comentari:
Publica un comentari a l'entrada